Changbin Zhu

1 article listing Changbin Zhu in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis Nature Communications